1058P A single-centre, prospective, open-label, single-arm trial of toripalimab with nab-paclitaxel and S-1 as a neoadjuvant therapy for esophageal squamous cell carcinoma (ESCC)
G. Zhang, Ya-guo Hu, Bo Yang, Qingyu Xu, J. Li, Shengyun Sun, J. Zhang, Shuo Jiao
Topics & Concepts
MedicineClinical endpointRegimenNeoadjuvant therapyInternal medicineChemotherapyOncologySurgerySurrogate endpointInterim analysisMalignancyChemotherapy regimenGemcitabineSingle CenterClinical trialCancerBreast cancerEsophageal Cancer Research and TreatmentCancer Immunotherapy and BiomarkersGastric Cancer Management and Outcomes